Citation: lueck s et al.Hydroxylapatite deposition induces graft alterations in chd patients.Cardiology in the young.2019; 29(supp.1):s84.Doi: 10.1017/s1047951119000489, earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information via literature regarding a retrospective analysis into the calcification-dependent alterations of various types of grafts in patients with congenital heart disease.All data were collected from a single center.The study population included 7 patients, 3 of whom were implanted with medtronic contegra pulmonary valved conduit (unique device identifier numbers not provided).Among all medtronic contegra patients, adverse events included: conduit explantation due to calcium-based deposits (calcium phosphates and hydroxylapatite).Based on the available information medtronic product was directly associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
|